Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Beginning Cash Balance (2023 - 2026)

BioScience Health Innovations has reported Beginning Cash Balance over the past 4 years, most recently at $150000.0 for Q1 2026.

  • Quarterly Beginning Cash Balance fell 71.26% to $150000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Mar 2026, up 78.06% year-over-year, with the annual reading at $3.2 million for FY2025, 195.04% up from the prior year.
  • Beginning Cash Balance was $150000.0 for Q1 2026 at BioScience Health Innovations, down from $990000.0 in the prior quarter.
  • Over five years, Beginning Cash Balance peaked at $990000.0 in Q4 2025 and troughed at $17952.0 in Q1 2023.
  • The 4-year median for Beginning Cash Balance is $286100.0 (2024), against an average of $395021.7.
  • Year-over-year, Beginning Cash Balance soared 1493.69% in 2024 and then plummeted 71.26% in 2026.
  • A 4-year view of Beginning Cash Balance shows it stood at $248093.0 in 2023, then soared by 31.6% to $326500.0 in 2024, then soared by 203.22% to $990000.0 in 2025, then crashed by 84.85% to $150000.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Beginning Cash Balance are $150000.0 (Q1 2026), $990000.0 (Q4 2025), and $800000.0 (Q2 2025).